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Type I interferonvirulence of H5N1 inﬂuenza viruses in humans are poorly understood, though
evidence of hyperinﬂammation and systemic viral replication has been reported. Plasmacytoid dendritic cells
(PDCs), a major source of type I interferon, potentially affect host defense against inﬂuenza viruses. To
analyze how inﬂuenza virus infection alters PDC function, we measured cytokine secretion from primary
human PDCs infected with high- or low-pathogenicity inﬂuenza viruses. IFN-α responses induced by H5N1
viruses were several-fold higher than those induced by low-pathogenicity strains; differences in the
secretion of the proinﬂammatory cytokines TNF-α and IP-10 were less pronounced, in contrast with ﬁndings
from human macrophage studies. Reassortant viruses bearing H5N1-derived NS genes did not elicit
enhanced IFN-α secretion by PDCs; thus, other H5N1 gene(s) are responsible for the heightened response.
Their central role in the induction of an effective antiviral immune response and the ﬁnding that they
respond differently to inﬂuenza viruses of different pathogenicities suggest that PDCs may play a role in the
hypercytokinemia associated with H5N1 infection in humans.
© 2008 Elsevier Inc. All rights reserved.IntroductionDuring the ﬁrst human H5N1 outbreak in 1997, 18 cases of H5N1
inﬂuenza A infection in humans were conﬁrmed, and more than 300
infected individuals have been diagnosed since 2003. H5N1 inﬂuenza
infection of humans causes severe pneumonia, systemic disease, and
mortality inmore than 50% of patients. H5N1 avian inﬂuenza Aviruses
(IAVs) are potential agents of pandemic inﬂuenza, but existing strains
are incapable of efﬁcient human-to-human transmission. Deﬁning the
viral and host factors that underlie these viruses' high pathogenicity is
crucial for the development of strategies to prevent and treat
infection. Studies of patients infected with H5N1 inﬂuenza have
shown that systemic viral replication can occur (e.g., RNA detection in
rectal swabs, blood, and postmortem tissue specimens) (de Jong et al.,
2005; de Jong et al., 2006; Uiprasertkul et al., 2005). However, viral
antigen has not been detected consistently outside the respiratory
tract of humans.
Several lines of evidence indicate that H5N1 inﬂuenza infection
triggers a massive inﬂammatory response (or hypercytokinemia) that
contributes to systemic tissue damage. First, data from H5N1 IAV-
infected patients reveal that inﬂammatory cytokine levels in blood can
elevate dramatically during severe infection (de Jong et al., 2006;
Peiris et al., 2004; To et al., 2001), and viral replication in the upper
respiratory tract correlates with increased concentrations of several ofdy).
l rights reserved.these cytokines (de Jong et al., 2006). Second, the expression of genes
that encode many cytokines and chemokines (e.g., IFN-α and -β,
interleukin (IL)-1β, MIP-1α, RANTES, TNF-α) is strongly induced in
human monocyte-derived macrophages infected with human H5N1
isolates (Cheung et al., 2002), and high levels of TNF-α and IP-10
proteins are secreted from macrophages infected with several H5N1
IAVs (Cheung et al., 2002; Guan et al., 2004). Third, in vitro H5N1
inﬂuenza infection of primary respiratory epithelial cells also induces
abundant transcription and expression of a subset of cytokines and
chemokines (e.g., IP-10, IL-6, and RANTES) (Chan et al., 2005). Thus,
there is in vivo and in vitro evidence for profuse release of cytokines
and chemokines during H5N1 IAV infection in humans.
The elevation of cytokine levels in H5N1 inﬂuenza patients
suggests that highly pathogenic H5N1 viruses cause skewing of the
innate immune response. Noteworthy among the innate immune
mediators involved in defense against inﬂuenza infection are the type
I interferons (IFNs), namely IFN-α, which restrict inﬂuenza virus
replication (Isaacs and Lindenmann, 1957) and promote the induction
of inﬂuenza-speciﬁc adaptive immune responses (Coro, Chang, and
Baumgarth, 2006; Ito et al., 2004). Plasmacytoid dendritic cells (PDCs)
are potent producers of IFN-α in response to infection with IAV or
other enveloped viruses (Siegal et al., 1999). PDCs are the principal
source of IFN-α in the lungs of mice infected with the inﬂuenza A
strain WSN (Jewell et al., 2007). PDCs are present in human lung
tissues and bronchoalveolar lavage ﬂuids (Demedts et al., 2005) and
can be recruited to the nasal mucosa during respiratory viral infection
(Gill et al., 2005). Considering these characteristics, PDCs may have an
Fig. 1. Characterization of IFN-α secretion from inﬂuenza-infected PDCs. IFN-α
concentrations were measured by ELISA in supernatants of primary human PDCs
infected in vitro with 5 MOI. (A) PDCs were either mock-infected (squares) or infected
with the laboratory strain PR8 (diamonds) and supernatants were sampled over a 44-
hour timecourse. (B) PDCs were infected with PR8, A/Memphis/14/98, A/Hong Kong/
213/03, or A/Vietnam/1203/04 and supernatants were sampled at 8, 20, and 32 h. (C)
PDCs were stimulated with mock infection, live A/Vietnam/1203/04 or BPL-inactivated
A/Vietnam/1203/04 (data shown are from one representative experiment out of three
performed with cells from different individuals).
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could have a pivotal inﬂuence on the regulation of inﬂammation
during H5N1 IAV infection.
The primary objective of these studies was to ascertain whether
high-pathogenicity (H5N1) or low-pathogenicity (H1N1 or H3N2)
inﬂuenza viruses affect the function of primary human PDC. Toward
this end, primary PDCs were isolated and infected with either high or
low-pathogenicity inﬂuenza viruses. As a measure of PDC function,
the differentially infected PDCs were assessed for the ability to secrete
several cytokines, including IFN-α. Having observed signiﬁcant
differences in cytokine production, we investigated potential
mechanisms for the strain-to-strain disparity in PDC stimulation.
Results of our experiments reveal novel modulatory effects of H5N1
IAVs upon the innate immune response. These data also suggest a role
for PDCs in establishing the ampliﬁed cytokine response observed in
clinical studies of H5N1 IAV infection.
Results
Secretion of IFN-α from inﬂuenza virus-infected PDCs
We analyzed the capacity of inﬂuenza viruses to induce secretion
of IFN-α from PDCs isolated from human blood. To determine virus
dose effects, we infected PDCs with PR8 virus at an MOI of 0.05, 1, 5,
and 25. IFN-α yields from cells infected at an MOI of 1, 5, or 25 were
similar, whereas the amount of IFN-α detected upon infection at an
MOI of 0.05 was markedly lower, suggesting that PDCs require
infection with only one virus particle for full induction of the IFN-α
response (data not shown). To determine the kinetic properties of the
PDC response to infection with PR8 virus, we analyzed IFN-α levels in
supernatants at various time points. Primary PDCs infected with PR8
at an MOI of 5 produced readily detectable IFN-α, whereas
noninfected cells secreted no detectable IFN-α. The concentration of
IFN-α in supernatants of PR8-infected cells increased from 14 to 32 h
after infection before a plateau in concentrationwas reached (Fig. 1A).
A sufﬁcient number of PDC were isolated from one donor to
compare the kinetics of parallel infections with inﬂuenza strains PR8
(H1N1), A/Memphis/14/98 (H3N2), A/Hong Kong/213/03 (H5N1), or
A/Vietnam/1203/04 (H5N1). IFN-α levels were determined by ELISA
at 8, 20, and 32 h postinfection to compare the kinetic response
elicited by different strains. IFN-α production in response to the two
H5N1 and two human-lineage strains followed roughly similar
kinetics. IFN-α levels were minimal at 8 h (0.2–5.6% of peak),
increased most sharply between 8 and 20 h (reaching 62–89% of
peak), and increased more modestly between 20 and 32 h (Fig. 1B).
PDCs isolated from additional donors were infected with the same
inﬂuenza virus strains for cytokine quantiﬁcation at 20 h (Fig. 2). IFN-α
secreted fromPR8-infected cells at 20 h ranged from0.65 to 5.15 ng/ml
(median, 2.65 ng/ml; n=6). Because the magnitude of responsiveness
to identical infections varied among individuals, cytokine levels
induced by each virus were normalized to those found in PDCs
contemporaneously infected with PR8 (Fig. 2A). The level of IFN-α
produced in response to infection with A/Memphis/14/98, a low-
pathogenicity virus, was similar to that produced with PR8.
Signiﬁcantly higher amounts of IFN-α were secreted from PDCs
infected with H5N1 virus A/Hong Kong/213/03 than with either PR8
(P<0.05) or A/Memphis/14/98 (P<0.005). Similarly, A/Vietnam/1203/
04 induced a higher IFN-α response than either low-pathogenicity
virus (P<0.005). Responses to the two H5N1 viruses did not differ from
each other (P=0.08), but A/Vietnam/1203/04 elicited the greatest IFN-α
response in all six experiments.
To test whether IFN-α induction depends on viral replication, we
incubated PDCs with either live A/Vietnam/1203/04 or a β-propio-
lactone inactivated preparation of the same virus stock. Inactivation of
the virus reduced its capacity to stimulate IFN-α secretion from PDCs
by approximately ten-fold (n=3, Fig. 1C), which indicates that viralreplicationmust at least be initiated to trigger abundant IFN-α release.
This is consistent with the over eight-hour lag before IFN-α is readily
detected from infected PDCs. We assessed the replication of PR8 and
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tion of a target sequence in M1 gene mRNA, normalized to GAPDH
mRNA level, 8 h postinfection. This experiment was performed in
duplicate using puriﬁed PDCs from two distinct donors. The relative
level of M1 transcription in A/Vietnam/1203/04-infected cells
exceeded that in PR8-infected cells by a factor of 2.3 in one experiment
and 2.8 in the other. Titers of both viruses in 20-hour supernatants
were very low (approximately 1 PFU/100 cells) and could not be
differentiated from residual inoculum (data not shown).
Secretion of inﬂammatory cytokines from inﬂuenza virus-infected PDCs
Infection of human macrophages with highly pathogenic H5N1
inﬂuenza viruses triggers an unusually high production of TNF-α and
the chemokine IP-10 (Guan et al., 2004). Therefore, we analyzed the
concentrations of these two inﬂammation mediators in the super-
natants of PDCs infected with low- or high-pathogenicity inﬂuenza
viruses. PDCs secreted readily detectable amounts of TNF-α in
response to infection with all of the viruses (Fig. 2B). Differences in
TNF-α induction by the different viruses were less pronounced than
those in IFN-α induction, though the virus that elicited the highest
median TNF-α response was also A/Vietnam/1203/04. The TNF-α
response to stimulation with A/Vietnam/1203/04 was signiﬁcantly
greater than responses to A/Memphis/14/98 (P<0.05) or A/Hong
Kong/213/03 (P<0.005). The levels of IP-10 in supernatants of infected
PDCs were also low in comparison with the levels of IFN-α. The
concentration of IP-10 induced by low-pathogenicity viruses did not
differ from that induced by high-pathogenicity viruses (Fig. 2C).
Role of NS genes in differential cytokine responses of infected PDCs
Because IAV NS1 protein is a known antagonist of type I IFN
production, we examined the effects of different NS genes on the
modulation of PDC function. The NS gene of PR8was replacedwith that
of A/Memphis/14/98, A/Hong Kong/213/03, or A/Vietnam/1203/04 to
generate reassortant viruses. Reassortant viruses were then used to
infect human PDCs. As was the case in experiments with wild-type
viruses, we observed across experiments large variations in the
magnitude of IFN-α released by infected PDCs (Fig. 3A). Thus, the
levels of IFN-α induced by reassortant viruses are presented in
proportion to that induced by PR8 in cells from the same individual.
NS genes derived fromH5N1 or H3N2 viruses and inserted into the PR8
background failed to enhance IFN-α production by infected PDCs,
relative to PR8 (Figs. 3A andB). Rather, signiﬁcantly less IFN-α secretion
was induced by infection with PR8-NSMem/14/98 or PR8-NSVN/1203/04
(P<0.05) than by infection with nonreassortant PR8. However, PR8-
NSHK/213/03 infection typically resulted in an IFN-α response compar-
able to that elicited by nonreassortant PR8.
To broaden our analysis of the effects of the NS gene on the cytokine
response of infected PDCs, we also used a multiplex assay to examine
TNF-α, IP-10, IL-8, IL-15, MIP-1α, MIP-1β, MCP-1, and RANTES (Fig. 4).
NS genes contributed by H5N1 or H3N2 viruses were not associated
with enhanced secretion of these molecules by PDCs, nor were they
generally associated with reduced production of these cytokines or
chemokines. A notable exception was that PDCs infected with PR8-
NSVN/1203/04 secreted signiﬁcantly less RANTES than cells infected withFig. 2. Secretion of cytokines from PDCs in response to low- and high-pathogenicity
IAVs. PDCs isolated from the peripheral blood of six human donors were aliquoted and
infected at an MOI of 5 with PR8, A/Memphis/14/98, A/Hong Kong/213/03, or A/
Vietnam/1203/04 viruses. Supernatants were collected 20 h postinfection, and the
concentrations of (A) IFN-α, (B) TNF-α, and (C) IP-10 were analyzed by ELISA. To
normalize for donor-to-donor variation, cytokine concentrations produced in response
to each virus are shown as percentages of the concentration produced in response to
PR8 within the same experiment. Each data point is denoted (diamonds), and the
median cytokine response to each virus is presented (horizontal bar). Statistically
signiﬁcant differences are denoted by ⁎ (P<0.05) or ⁎⁎ (P<0.005).
Fig. 3. IFN-α production by PDCs infectedwith reassortant PR8 viruses bearing different
NS genes. PDCs from ﬁve donors were aliquoted and infected with PR8 or recombinant
viruses at an MOI of 5 (n=3 for PR8-NSMem/14/98 infection). (A) Supernatants were
collected at 20 h postinfection, and IFN-α concentrations were determined bymultiplex
assay. Cytokine concentrations produced in response to each virus are plotted as
changes relative to the concentrations of cytokines elicited by infection with PR8.
Horizontal bars denote the median levels of IFN-α induced by each virus. Statistically
signiﬁcant differences in IFN-α induction between parent virus PR8 and reassortant PR8
viruses are indicated by ⁎ (P<0.05). (B) The IFN-α concentrations resulting from
infection of PDCs with each wild-type inﬂuenza virus (black bars) are compared with
those elicited with reassortant PR8 viruses bearing the corresponding NS gene
segments (gray bars).
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signiﬁcantly less MIP-1α than did PR8 (P<0.05).
Discussion
Since the initial outbreak of highly virulent H5N1 in humans in
1997, deregulated cytokine responses have been linked with severe
disease in clinical and animal studies. The cytokine hyperinduction in
humans has been further characterized by ex vivo infection of
immune cell populations, chieﬂy human macrophages, and respira-
tory epithelial cells (Chan et al., 2005; Cheung et al., 2002; Zhou et al.,
2006). These studies have involved a relatively narrow phylogenic
range of viruses and cellular specimens sampled from a small number
of human subjects. Nonetheless, a trend has been established: H5N1
viruses typically elicit higher levels of certain cytokines such as TNF-α,
RANTES, and IP-10 compared with less virulent inﬂuenza A strains.
The degree to which type I IFNs are induced and affect the immune
response to H5N1 inﬂuenza infection is less clear, perhaps due to the
diversity and tissue-speciﬁc distribution of IFN-secreting cells. Theeffects of type I IFNs on viral replication and the downstream
inﬂammatory cascades might have a marked impact on disease
severity in human H5N1 patients. PDCs are proliﬁc producers of type I
IFNs, and as such, may have a pivotal inﬂuence on the host response
during low- or high-pathogenicity inﬂuenza virus infection.
PDCs are uniquely equipped to respond to viral stimuli, including
inﬂuenza virus. In vitro studies have established that inﬂuenza virus
elicits strong IFN-α production from PDCs (Diebold et al., 2004), and
PDCs are reportedly less prone than conventional dendritic cells to
NS1-mediated suppression of the IFN-α response (Diebold et al.,
2003). TLR7/9 receptors of PDCs recognize single-stranded viral RNA,
such as the inﬂuenza virus genome, and trigger IFN-α production
(Asselin-Paturel and Trinchieri, 2005; Diebold et al., 2004), but
replication-dependent IFN-α responses to viral stimuli have also
been reported (Hornung et al., 2004). Constitutive expression of the
transcription factor IRF-7 and optimal retention of MyD88–IRF-7
complexes in the endosome also facilitate the potent cytokine response
of virus-infected PDCs. PDCs migrate to lymphoid organs where they
modulate the activation of lymphocytes (Cella et al., 2000; Jego et al.,
2003). PDCs also trafﬁc through respiratory tissues (Gill et al., 2005;
Tsoumakidou et al., 2006), suggesting that these cells function as
sentinels and early antiviral effectors in the respiratory tract.
In a previous study, a highly pathogenic avian H5N1 IAV elicited
ample IFN-α secretion from human PDCs (Thitithanyanont et al.,
2007). In our study, we compared low-pathogenicity human-lineage
viruses with two highly pathogenic H5N1 virus isolates. Among
replicate experiments with PDCs from multiple donors, A/Vietnam/
1203/04 (H5N1) frequently elicited an IFN-α response several-fold
higher than that elicited by the less virulent H1N1 or H3N2 viruses.
We demonstrated that induction of IFN-α from PDCs by A/Vietnam/
1203/04 is largely dependent on the virus' viability. Quantiﬁcation of
viral messenger RNA in cells infected with PR8 versus A/Vietnam/
1203/04 (low versus high IFN-α-inducing viruses, respectively)
revealed evidence of a possible association between viral gene
replication efﬁciency and the intensity of IFN-α induction. It is
noteworthy that others previously reported a relatively high
efﬁciency of A/Vietnam/1203/04 polymerase complex in mammalian
cells and linked this to the virus' virulence in ferrets (Salomon et al.
2006). We also measured the concentrations of the inﬂammatory
mediators TNF-α and IP-10, both of which are secreted in abundance
from human monocyte-derived macrophages after infection with
various H5N1 inﬂuenza viruses (Cheung et al., 2002; Guan et al.,
2004). We observed that PDCs, in contrast to macrophages, secrete
similar quantities of TNF-α and IP-10 in response to H5N1 viruses as
to low-pathogenicity IAV strains. The fact that exceptional IFN-α
production was not coupled with especially high TNF-α or IP-10
production in H5N1 inﬂuenza-infected PDCs probably reﬂects the
differences in cytokine specialization between PDCs andmacrophages.
The inﬂuenza NS1 protein has been characterized as a type I IFN
antagonist that is crucial for efﬁcient viral replication (Wang et al.,
2000; Solorzano et al., 2005). How the abundant IFN-α secretion
noted in our study harmonizes with the high pathogenicity of H5N1
viruses remains unclear. One explanation could be inferred from a
previous report that the NS1 genes of H5N1 inﬂuenza viruses mediate
resistance to the antiviral effects of IFN-α and TNF-α in infected
porcine lung epithelial cells (Seo, Hoffmann, and Webster, 2002). In
another study, NS1 of highly pathogenic A/Hong Kong/486/97 (H5N1)
contributed to the robust TNF-α response of monocyte-derived
macrophages infected in vitro (Cheung et al., 2002). Taken together,
these ﬁndings suggest that unique NS1 properties may permit highly
pathogenic H5N1 viruses to replicate efﬁciently in mammalian hosts
despite an exceptional cytokine response.
To further characterize the role of NS1 in H5N1 viral infections, we
infected PDCs with reassortant viruses differing only in the NS gene
segment and assessed cytokine production. This revealed that an
H5N1-derived NS1 gene alone cannot confer an elevated cytokine
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conclude that the exceptional IFN-α-inducing property of the H5N1
viruses in PDCs is not caused by ineffective NS1 proteins with weak
IFN antagonism properties. This is consistent with a recent report that
NS1 proteins of several diverse avian IAV strains retain inhibitory
properties against IFN gene expression in mammalian cells (Hayman
et al., 2007). Rather, it appears that other genes of the highly
pathogenic H5N1 viruses are required for enhanced cytokine
secretion, and identifying the roles of these genes will require further
study. Of note, recombinant viruses bearing the NS gene segments of
A/Memphis/14/98 (H3N2) and A/Vietnam/1203/04 (H5N1) elicited
signiﬁcantly lower IFN-α responses by PDCs than the nonreassortant
PR8 virus. In an analogous ﬁnding, others showed that differences in
IFN-β induction by several human H3N2 IAV strains in tested cell lines
do not always correspond with differences in IFN antagonism by their
respective NS1 proteins (Hayman et al., 2006). One reason for this lack
of correlation between NS1 antagonism and PDC IFN-α responses
could be the ﬁtness of a given inﬂuenza virus strain, suggesting that
avian H5N1 strains crossing a species barrier to humans have not
adapted in this regard.
We have shown that two pathogenic H5N1 viruses induce higher
levels of type I IFN secretion by PDCs than low-pathogenicity human-
lineage IAVs. The collective evidence that H5N1 inﬂuenza viruses
elicit a potent type I IFN response from human PDCs and a robust
TNF-α response from macrophages is consistent with the idea that
the severe pathogenesis of H5N1 infection in humans is driven, in
part, by inﬂammation. Natural mutations causing an H5N1 strain to
better suppress the type I IFN response of PDCs might reduce its
pathogenicity and increase its ﬁtness for replication and transmission
in humans.
Materials and methods
Cells
Peripheral blood from healthy donors was purchased from
Lifeblood Biological Services (Memphis, TN). Components of periph-
eral blood were separated by counter-ﬂow centrifugal elutriationwith
the Elutra cell separation system (Gambro BCT, Inc., Lakewood, CO).
Under this protocol, immature PDCswere coenrichedwithmonocytes.
PDCs were magnetically labeled with BDCA-4 microbeads (Miltenyi
Biotec, Auburn, CA) and separated by positive selection with an
autoMACS™ Separator (Miltenyi) in accordance with the manufac-
turer's instructions. The purity of cell preparations was assessed by
ﬂow cytometry with directly conjugated anti-BDCA-2 monoclonal
antibodies (Miltenyi). The purity of the PDC populations ranged from
84% to 96% among the 11 donors; median purity was 93%.
Viruses
Human H5N1 IAVs included in this study, A/Hong Kong/213/03
and A/Vietnam/1203/04, were obtained from the World Health
Organization H5 Reference Laboratory Network. The human H3N2
virus A/Memphis/14/98 was obtained from the repository of St. Jude
Children's Research Hospital. Recombinant inﬂuenza viruses that
contained NS genes from each of these viruses and a background of
genes isolated from the laboratory strain A/Puerto Rico/8/34 (PR8)
(H1N1) were rescued by eight-plasmid reverse genetics (Hoffmann
et al., 2000). A/Vietnam/1203/04 virus was chemically inactivated
with 0.05% β-propiolactone (BPL) for 24 h and subsequently the BPL
was inactivated for 30 min at 37 °C.Fig. 4. Cytokine and chemokine production by PDCs infected with reassortant PR8 viruses be
PR8 or recombinant viruses at an MOI of 5 for 20 h, followed bymultiplex evaluations of cytok
MIP-1α, MIP-1β, RANTES, and TNF-α produced in response to each virus are normalized
between the effects of parent PR8 virus and reassortant PR8 viruses are indicated by † (P<0Plasmids encoding each of the PR8 genes were described previously
(Hoffmann et al., 2002). RNAwas isolated from A/Hong Kong/213/03, A/
Vietnam/1203/04, and A/Memphis/14/98 and reverse transcribed into
DNA templates for ampliﬁcation of NS genes, as previously described
(Hoffmann et al., 2001). NS genes of A/Hong Kong/213/03 (NSHK/213/03),
A/Vietnam/1203/04 (NSVN/1203/04), and A/Memphis/14/98 (NSMem/14/98)
were ligated into the plasmid pHW2000. These recombinant plasmids
and the seven complementary plasmids encoding all PR8 genes except
NS were used to cotransfect mixed cultures of Madin–Darby canine
kidney (MDCK) and 293T cells (Hoffmann et al., 2000). PR8 virus with
its native NS gene was generated by the same protocol. Wild-type and
recombinant viruses were propagated in 10-day-old embryonated
chicken eggs, except for A/Memphis/14/98, which required culture in
MDCK cell culture. NS genes from the egg-grown recombinant viruses
were sequenced and conﬁrmed tomatch those of the original wild-type
H5N1 viruses. The control for mock infection of PDCs was allantoic ﬂuid
from noninfected eggs.
In vitro infections
PDC growth medium consisted of serum-free CellGenix™ DC
medium (CellGenix, Frieburg, Germany) plus penicillin (100 U/ml),
streptomycin (100 μg/ml), and amphotericin B (250 ng/ml) (Invitro-
gen, Carlsbad, CA). PDCs suspended in growth medium were infected
with inﬂuenza viruses at a multiplicity of infection (MOI) of 5 plaque-
forming units (PFUs) per cell and allowed to incubate for 45 min at
37 °C. Cells were washed in fresh medium, resuspended to 7×105/ml,
and dispensed into ﬂat-bottom cell culture plates. Supernatants were
sampled at the indicated times to examine the kinetics of the PDC
response. In vitro PDC infection experiments with H5N1 IAV isolates
were performed under BSL-3+ laboratory conditions. Trypan blue
exclusion was used to compare the viability of mock-infected PDCs
and PR8-infected PDCs maintained in culture at 20 h postinfection.
The viability of inﬂuenza-infected PDCs (range, 82%–97%) was higher
than that of mock-infected PDCs (range, 49%–95%; three experiments).
This is consistent with a report that H5N1 IAV-infected PDCs maintain
high viability (Thitithanyanont et al., 2007).
Measurement of cytokine concentrations
The concentration of IFN-α in supernatant from PDCs was
determinedwith a commercial ELISA kit (PBL Biomedical Laboratories,
Piscataway, NJ). Concentrations of other secreted cytokines were
measured using the human Cytokine 25-Plex AB Bead Kit (Biosource
International, Inc., Camarillo, CA). The multiplex assay was analyzed
on a Bio-Plex array reader (Bio-Rad Laboratories, Inc., Hercules, CA).
For experiments carried out under BSL-3+ conditions, TNF-α and IP-10
were analyzed by ELISA (Quantikine Immunoassays, R&D Systems,
Minneapolis, MN).
Real-time reverse transcriptase PCR
Real-time reverse transcriptase polymerase chain reaction was
used to assess inﬂuenza virus replication in PDC samples. Eight hours
after infection of PDC from two donors with A/Vietnam/1203/04 and
A/PR/8/34 virus (MOI=5) RNA was extracted using a Qiagen RNA
extraction kit (Qiagen, Valencia, CA). cDNA was produced from the
RNA using dT primers and Superscript RT III (Invitrogen, Carlsbad, CA)
according to manufacturer's instructions. Matrix protein 1 mRNA was
quantiﬁed using a previously describedM1 primer–probe set (Di Trani
et al., 2006) and compared to that of a house-keeping control genearing different NS genes. PDCs from ﬁve donors were aliquoted and infected with parent
ines (n=3 for PR8-NSMem/14/98 infection). The concentrations of IL-8, IL-15, IP-10, MCP-1,
to their respective concentrations elicited by PR8. Statistically signiﬁcant differences
.05) and that between PR8-NSMem/14/98 and PR8-NSVN/1203/04 is indicated by ‡ (P<0.05).
28 M.R. Sandbulte et al. / Virology 381 (2008) 22–28(GAPDH). Delta Ct values were determined for both virus-PDC samples
and the difference between delta Ct values was used to determine the
difference in the amount of M1 mRNA between PR8 and A/Vietnam/
1203/04 virus-infected PDCs.
Statistics
The differences in cytokine induction by different viruses were
analyzed by using SAS software (SAS Institute, Cary, NC) and themixed
model for randomized block design and blocking on donor. The
distribution of the concentrations of each cytokine was normalized by
logarithm transformation.
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